Page last updated: 2024-08-21

malondialdehyde and sulindac

malondialdehyde has been researched along with sulindac in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Damas, J; Volon, G1
Facoory, B; Faed, JM; McQueen, EG1
Akman, T; Aras, AB; Cosar, M; Deniz, M; Guven, M; Kaner, T; Memi, G; Ozkan, A; Sahin, O; Sen, HM; Topaloglu, N1
Chattopadhyay, M; Kashfi, K; Kodela, R1
Ansari, M; Jomehzadeh, A; Nabizadeh Haghighi, F; Rezaeifar, M; Torabizadeh, SA1

Trials

1 trial(s) available for malondialdehyde and sulindac

ArticleYear
Non-steroidal anti-inflammatory drugs and platelet function.
    The New Zealand medical journal, 1986, May-28, Volume: 99, Issue:802

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Diflunisal; Female; Humans; Male; Malondialdehyde; Middle Aged; Naproxen; Piroxicam; Sulindac; Time Factors

1986

Other Studies

4 other study(ies) available for malondialdehyde and sulindac

ArticleYear
[Effect of oxamethacin and sulindac on prostaglandin synthesis].
    Comptes rendus des seances de la Societe de biologie et de ses filiales, 1979, Volume: 173, Issue:4

    Topics: Animals; Arachidonic Acids; Blood Platelets; Blood Pressure; Gastric Mucosa; Indenes; Indomethacin; Malondialdehyde; Prostaglandins; Rats; Stomach; Sulindac

1979
The neuroprotective effect of Sulindac after ischemia-reperfusion injury in rats.
    Acta cirurgica brasileira, 2014, Volume: 29, Issue:4

    Topics: Animals; Apoptosis; Brain Ischemia; Cyclooxygenase Inhibitors; Disease Models, Animal; Glutathione; Hippocampus; Infusions, Parenteral; Malondialdehyde; Neuroprotective Agents; Oxidative Stress; Peroxidase; Rats, Sprague-Dawley; Reperfusion Injury; Reproducibility of Results; Sulindac

2014
NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.
    Redox biology, 2015, Volume: 6

    Topics: Administration, Oral; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antipyretics; Cell Line, Tumor; Cell Survival; Dinoprostone; Edema; Fever; Hydrogen Sulfide; Hyperalgesia; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Donors; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Sulindac; Superoxide Dismutase

2015
Radioprotective Potential of Sulindac Sulfide to Prevent DNA Damage Due to Ionizing Radiation.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Antioxidants; DNA Damage; Dose-Response Relationship, Drug; Humans; Lipid Peroxidation; Lymphocytes; Malondialdehyde; Molecular Structure; Radiation Protection; Structure-Activity Relationship; Sulindac; Superoxide Dismutase

2019